Quantbot Technologies LP Sells 28,091 Shares of Option Care Health, Inc. $OPCH

Key Points

• Quantbot Technologies LP has reduced its stock position in Option Care Health, Inc. by 27.1%, selling 28,091 shares to end up with a total of 75,530 shares worth approximately $2.64 million.
• Institutional investors hold 98.05% of Option Care Health's stock, with notable increases in holdings observed from firms such as Dimensional Fund Advisors and Allspring Global Investments.
• Recent analyst activity has been positive, with multiple firms raising their target price for Option Care Health, resulting in a consensus "Moderate Buy" rating and a price target of $35.75.

Quantbot Technologies LP reduced its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 27.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 75,530 shares of the company's stock after selling 28,091 shares during the period. Quantbot Technologies LP's holdings in Option Care Health were worth $2,640,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its holdings in Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Northern Trust Corp lifted its holdings in Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after purchasing an additional 278,158 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Option Care Health by 4.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company's stock valued at $91,209,000 after purchasing an additional 99,574 shares during the last quarter. Nuveen LLC bought a new position in Option Care Health during the 1st quarter valued at about $70,965,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Option Care Health by 6,525,926.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after purchasing an additional 1,500,963 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, with a total value of $977,400.00. Following the completion of the purchase, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. This represents a 10.61% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy P. Sullivan purchased 20,000 shares of the company's stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the purchase, the director owned 49,229 shares of the company's stock, valued at $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.64% of the company's stock.

Option Care Health Price Performance

Shares of OPCH stock traded up $0.90 during trading hours on Friday, reaching $28.74. 2,369,675 shares of the company were exchanged, compared to its average volume of 1,937,741. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The company has a market cap of $4.66 billion, a price-to-earnings ratio of 22.99, a P/E/G ratio of 1.82 and a beta of 0.79. The stock's fifty day moving average is $29.92 and its two-hundred day moving average is $31.75. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. Option Care Health's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on OPCH shares. JMP Securities increased their target price on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.